0 The best of 2018 – an A–Z of infectious diseases research
Want to discover the best research that’s occurred this year? Editor, Martha Powell, highlights the best of 2018’s infectious diseases research in an A–Z.
Browsing: Disease Area > Viral
0 Ebola outbreak in the Democratic Republic of Congo is second worst ever recorded
Ebola case numbers reach 426 in the current outbreak in the Democratic Republic of Congo, making this the second largest ever seen for the virus.
0 Aging in HIV – an interview with Andy Ustianowski
In line with World AIDS Day this year we spoke to Andy Ustianowski (North Manchester General Hospital, UK) about the new challenges facing people living with HIV, including aging healthily and happily.
0 Measles resurgence due to vaccination coverage gaps, according to WHO
A WHO report has indicated that measles cases spiked globally due to gaps in vaccination coverage, as many countries experienced severe outbreaks.
0 HIV: decreasing diagnoses means UK hits international targets for the first time
Declining HIV diagnoses in the UK have been highlighted in a recent report from Public Health England, meaning that for the first time UN targets have been reached.
0 Freeze-dried polio vaccine could avoid cold chain issues
Researchers have developed a freeze-dried polio vaccine that doesn’t require refrigeration and is still efficacious after rehydration.
0 First-ever multi-drug Ebola trial launched in the Democratic Republic of Congo
A new trial has begun in the Democratic Republic of Congo, aiming to collect robust data on the safety and efficacy of investigational Ebola therapeutics.
0 Gastroenteritis in children unscathed by treatment with probiotics
Concurrent major US and Canadian clinical trials prove probiotics to be ineffective in combatting gastroenteritis in children.
0 Vaccinia virus hijacks host cell motility to aid spread
New research has suggested that vaccinia viruses trick infected host cells into activating their cell movement mechanism, rapidly spreading the virus.
0 Influenza: a promising universal llama-derived antibody therapy
Collaborative research efforts with scientists from Janssen, the Scripps Research Institute, the University of Hong Kong, the University of Pennsylvania and more has led to success in creating a promising novel long-lasting llama-derived antibody therapy for influenza.
